Topic Editors

Assistant Professor of Surgery, Department of General Surgery, Sapienza UniversitĂ  di Roma, Rome, Italy
Associate Professor of Surgery, Department of Surgical Sciences, HPB and Transplant Unit, University of Rome Tor Vergata, Rome, Italy
Dr. Chiara Mazzarelli
Hepatology and Gastroenterology ASSTGOM Niguarda, Milan, Italy

Hepatobiliary and Pancreatic Diseases: Novel Strategies of Diagnosis and Treatments—Second Edition

Abstract submission deadline
20 September 2026
Manuscript submission deadline
25 November 2026
Viewed by
32

Topic Information

Dear Colleagues,

Following the success of the first edition, we are pleased to announce the Second Edition of the Topic Issue “Hepatobiliary and Pancreatic Diseases: Novel Strategies of Diagnosis and Treatments.”

Diseases of the liver and pancreas continue to represent a crucial field of interest in clinical, surgical, and translational research. Both benign conditions, such as hepatitis or pancreatitis, and malignant tumors significantly impact patients’ quality of life and survival, highlighting the need for continuous innovation in diagnostic and therapeutic strategies.

In recent years, malignant tumors of the liver, biliary tract, and pancreas have shown a worrying increase in incidence and mortality worldwide. These challenges reinforce the urgent need for novel approaches aimed at improving early detection, precision diagnosis, and effective treatment.

This new edition particularly welcomes original studies and reviews exploring the application of radiomics and artificial intelligence in hepatobiliary and pancreatic diseases. These emerging technologies promise to revolutionize how we interpret imaging data, stratify patient risk, and personalize therapeutic strategies.

We therefore invite researchers and clinicians to contribute their most innovative work, spanning medical, surgical, and technological perspectives, to further advance the understanding and management of HPB pathologies.

Dr. Alessandro Coppola
Dr. Roberta Angelico
Dr. Chiara Mazzarelli
Topic Editors

Keywords

  • liver benign disease
  • pancreas benign disease
  • chronic liver disease
  • chronic pancreatitis
  • pancreatitis
  • liver cancer
  • biliary cancer
  • pancreatic cancer
  • liver surgery
  • pancreas surgery

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Cancers
cancers
4.4 8.8 2009 20.3 Days CHF 2900 Submit
Diagnostics
diagnostics
3.3 5.9 2011 21 Days CHF 2600 Submit
Journal of Clinical Medicine
jcm
2.9 5.2 2012 17.7 Days CHF 2600 Submit
Biomedicines
biomedicines
3.9 6.8 2013 17 Days CHF 2600 Submit
Gastrointestinal Disorders
gastrointestdisord
0.8 1.2 2019 19.2 Days CHF 1400 Submit
Current Oncology
curroncol
3.4 4.9 1994 21.5 Days CHF 2200 Submit
Therapeutics
therapeutics
- - 2024 15.0 days * CHF 1000 Submit

* Median value for all MDPI journals in the first half of 2025.


Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.

MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:

  1. Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
  2. Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
  3. Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
  4. Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
  5. Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers

This Topic is now open for submission.
Back to TopTop